Unexpectedly, PTPRK has been shown to be highly expressed in breast and prostate cancer tissues as compared to their corresponding non‐tumor ones 15, 16, raising the possibility that the tumor suppressive function(s) but not the expression of PTPRK might be impaired in cancer cell‐derived spheres as well as cancer tissues. This evidence concerns the gene PTPRK and prostate carcinoma.